BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 9, 2012
View Archived Issues
Shionogi reports milestones of second quarter of fiscal 2012
Read More
Nonviral gene therapy for heart failure presented at AHA meeting
Read More
Kancera reports preclinical data for pancreatic cancer compounds
Read More
Phase III results reported for Ruconest in acute hereditary angioedema
Read More
Senesco Technologies expands study of SNS01-T
Read More
Auxilium and Pfizer to terminate European agreement for Xiapex
Read More
Auxilium seeks approval of new indication for Xiaflex in the U.S.
Read More
Clinical benefit of GLPG-0634 in rheumatoid arthritis confirmed in phase IIa trial
Read More
FDA grants fast track status for etirinotecan pegol in metastatic breast cancer
Read More
Albireo obtains FDA orphan drug designation for A-4250 in liver diseases
Read More
Catalyst Pharmaceutical reports results from phase IIb CPP-109 trial
Read More
Signifor recommended by FDA advisory committee for Cushing's disease
Read More
T-3256336 proven to be a highly effective inhibitor of tumor growth in vivo
Read More
IMA-901 receives FDA orphan designation, phase III study completes enrollment
Read More
Cornerstone acquires U.S. rights to Chiesi's Bethkis for cystic fibrosis
Read More
Merck & Co. presents novel BACE inhibitors
Read More
Laboratoire Biodim discloses new agents for HIV infection
Read More
Ironwood Pharmaceuticals submits IND for antianxiety drug candidate
Read More
Sloan-Kettering Institute for Cancer Research patents new HSP 90 inhibitors
Read More
Nektar Therapeutics synthesizes promising thymidylate synthase inhibitor
Read More
FDA accepts to review NDA for suvorexant in insomnia
Read More
Scientists at Vertex Pharmaceuticals patent new protein kinase inhibitors
Read More
Merck & Co. prepares novel agents for diabetes and obesity
Read More
Pfizer divulges new lpxC inhibitors for bacterial infections
Read More
Cryopraxis and CellPraxis plan phase III trial of cell therapy for refractory angina
Read More